Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. Managing the symptoms and preventing disease progression are key goals of treatment. Corticosteroids are one of the medications used in the management of AS, but their role is specific and carefully considered.

Understanding Corticosteroids

Corticosteroids are anti-inflammatory drugs that mimic the effects of hormones produced by the adrenal glands. They help reduce inflammation and suppress immune responses, providing relief from pain and swelling in inflammatory conditions like AS.

The Role of Corticosteroids in AS Treatment

In ankylosing spondylitis, corticosteroids are mainly used to manage flare-ups or active inflammation. They are not typically used as a long-term solution due to potential side effects. Instead, they serve as an adjunct to other medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and biologics.

Local vs. Systemic Use

Corticosteroids can be administered locally through injections directly into painful joints or entheses. This approach provides targeted relief with fewer systemic effects. Systemic corticosteroids, taken orally or intravenously, are reserved for severe cases or specific situations under careful medical supervision.

Benefits and Risks

The benefits of corticosteroids include rapid reduction of inflammation and pain, which can improve quality of life during active disease phases. However, prolonged use carries risks such as osteoporosis, weight gain, hypertension, and increased susceptibility to infections. Therefore, their use is carefully balanced and monitored.

Conclusion

Corticosteroids play a valuable role in managing specific aspects of ankylosing spondylitis, particularly during flare-ups or localized inflammation. Their use must be judicious and tailored to individual patient needs, often in combination with other therapies for optimal disease control.